会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Substituted 1-(alkoxy-iminoalkyl) imidazole derivatives and their use in
treating disease related to an enhancement of thromboxane-A.sub.2
syntheis
    • 取代的1-(烷氧基 - 亚氨基烷基)咪唑衍生物及其在治疗与凝血恶烷-A2合成增强有关的疾病中的用途
    • US5280033A
    • 1994-01-18
    • US768568
    • 1991-10-25
    • Paolo CozziMarla MenichincheriArsenia RossiCorrado FertiPatricia Salvati
    • Paolo CozziMarla MenichincheriArsenia RossiCorrado FertiPatricia Salvati
    • A61K31/415A61P3/06A61P13/02A61P15/00A61P43/00C07D233/61C07D521/00C07F7/08A61K31/44C07D409/06
    • C07D231/12C07D233/56C07D249/08C07F7/0812
    • 1-(Alkoxy-iminoalkyl)imidazole derivatives of formula ##STR1## wherein R is hydrogen or C.sub.1 -C.sub.4 alkyl; A is C.sub.1 -C.sub.4 alkylene optionally substituted by phenyl optionally substituted by halogen or trifluoromethyl; R is (a) hydrogen or a C.sub.1 -C.sub.10 hydrocarbon radical; (b) an aryl or aryl-C.sub.1 -C.sub.4 alkyl group wherein the said aryl is optionally substituted either by halogen, trihalo-methyl, C.sub.1 -C.sub.4 alkyl, C.sub.2 -C.sub.3 alkenyl, C.sub.2 -C.sub.6 alkynyl, C.sub.1 -C.sub.4 alkoxy, C.sub.1 -C.sub.4 alkylthio or C.sub.1 -C.sub.4 alkylsulfonyl or by C.sub.5 -C.sub.8 alkyl, C.sub.4 -C.sub.8 alkenyl, C.sub.5 -C.sub.8 alkoxy, C.sub.5 -C.sub.8 alkylthio or phenyl optionally substituted by halogen, trihalomethyl or C.sub.1 -C.sub.4 alkyl; or (c) a C.sub.5 -C.sub.8 cycloalkyl or C.sub.5 -C.sub.8 cycloalkyl-C.sub.1 -C.sub.4 alkyl group, wherein the said cycloalkyl is optionally substituted by C.sub.1 -C.sub.4 alkyl; T is a C.sub.1 -C.sub.6 hydrocarbon chain or phenylene; X is a bond, --O--CH.sub.2 --, --C(R' R")--, Si(R' R")--, vinylene or isopropenylene, each R' and R" being hydrogen, fluorine or C.sub.1 -C.sub.4 alkyl; and R.sub.2 is --OR.sub.3 or --N(R.sub.3 R.sub.4), each R.sub.3 and R.sub.4 being hydrogen, C.sub.1 -C.sub.6 alkyl, phenyl or benzyl; and the pharmaceutically acceptable salts thereof; are useful in the treatment of a disease state related to enhancement of thromboxane A.sub.2 (TxA.sub.2) synthesis.
    • 式(I)的1-(烷氧基亚氨基烷基)咪唑衍生物,其中R是氢或C 1 -C 4烷基; A是任选被任选被卤素或三氟甲基取代的苯基取代的C 1 -C 4亚烷基; R是(a)氢或C 1 -C 10烃基; (b)芳基或芳基-C 1 -C 4烷基,其中所述芳基任选被卤素,三卤代甲基,C 1 -C 4烷基,C 2 -C 3烯基,C 2 -C 6炔基,C 1 -C 4烷氧基, C 1 -C 4烷基磺酰基或C 5 -C 8烷基,C 4 -C 8烯基,C 5 -C 8烷氧基,C 5 -C 8烷硫基或任选被卤素,三卤代甲基或C 1 -C 4烷基取代的苯基; 或(c)C 5 -C 8环烷基或C 5 -C 8环烷基-C 1 -C 4烷基,其中所述环烷基任选被C 1 -C 4烷基取代; T是C1-C6烃链或亚苯基; X是键,-O-CH 2 - , - C(R'R“) - ,Si(R'R”) - 亚乙烯基或异亚丙基,每个R'和R“是氢,氟或C1- C4烷基; 并且R 2是-OR 3或-N(R 3 R 4),每个R 3和R 4是氢,C 1 -C 6烷基,苯基或苄基; 及其药学上可接受的盐; 可用于治疗与凝血恶烷A2(TxA2)合成增强相关的疾病状态。